Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss

Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss

Whether public and private insurance plans should cover GLP-1 agonists when prescribed primarily for weight loss…

Continue Reading
Many US employers plan to pare health benefits as weight-loss spending soars

Many US employers plan to pare health benefits as weight-loss spending soars

(Corrects July 16 story in paragraph 13 to show the contracts are based on acquisition cost,…

Continue Reading
LifeSpeak Inc. Expands Weight Management Libraries and Wellbeing Solutions with New GLP-1 Resources to Help Employers and Health Plans Maximize Their Investment in GLP-1s

LifeSpeak Inc. Expands Weight Management Libraries and Wellbeing Solutions with New GLP-1 Resources to Help Employers and Health Plans Maximize Their Investment in GLP-1s

By making LifeSpeak Inc.’s whole-person wellbeing solutions part of their GLP-1 strategy, employers and health plans…

Continue Reading
Wegovy, Ozempic cost a pretty penny. Many employers don’t want to pay

Wegovy, Ozempic cost a pretty penny. Many employers don’t want to pay

Kiana Price dropped 35 pounds after she started taking the weight-loss medication Wegovy last year. The…

Continue Reading